These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10837555)

  • 1. The effects of diet, aging and disease-states on presystemic elimination and oral drug bioavailability in humans.
    Wilkinson GR
    Adv Drug Deliv Rev; 1997 Sep; 27(2-3):129-159. PubMed ID: 10837555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis.
    Murray M
    Curr Drug Metab; 2006 Jan; 7(1):67-81. PubMed ID: 16454693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans.
    Wilkinson GR
    J Pharmacokinet Biopharm; 1996 Oct; 24(5):475-90. PubMed ID: 9131486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.
    Thummel KE; O'Shea D; Paine MF; Shen DD; Kunze KL; Perkins JD; Wilkinson GR
    Clin Pharmacol Ther; 1996 May; 59(5):491-502. PubMed ID: 8646820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction.
    Shen DD; Kunze KL; Thummel KE
    Adv Drug Deliv Rev; 1997 Sep; 27(2-3):99-127. PubMed ID: 10837554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing in vitro and PBPK tools to link ADME characteristics to plasma profiles: case example nifedipine immediate release formulation.
    Wagner C; Thelen K; Willmann S; Selen A; Dressman JB
    J Pharm Sci; 2013 Sep; 102(9):3205-19. PubMed ID: 23696038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of diet and nutritional status on drug metabolism.
    Walter-Sack I; Klotz U
    Clin Pharmacokinet; 1996 Jul; 31(1):47-64. PubMed ID: 8827399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between grapefruit juice and cardiovascular drugs.
    Bailey DG; Dresser GK
    Am J Cardiovasc Drugs; 2004; 4(5):281-97. PubMed ID: 15449971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone.
    Kharasch ED; Hoffer C; Whittington D; Sheffels P
    Clin Pharmacol Ther; 2004 Sep; 76(3):250-69. PubMed ID: 15371986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-pass elimination. Basic concepts and clinical consequences.
    Pond SM; Tozer TN
    Clin Pharmacokinet; 1984; 9(1):1-25. PubMed ID: 6362950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of drug metabolism in man by environmental chemicals and diet.
    Conney AH; Pantuck EJ; Hsiao KC; Kuntzman R; Alvares AP; Kappas A
    Fed Proc; 1977 Apr; 36(5):1647-52. PubMed ID: 844609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4.
    Bhardwaj RK; Glaeser H; Becquemont L; Klotz U; Gupta SK; Fromm MF
    J Pharmacol Exp Ther; 2002 Aug; 302(2):645-50. PubMed ID: 12130727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal first pass metabolism of midazolam in liver cirrhosis --effect of grapefruit juice.
    Andersen V; Pedersen N; Larsen NE; Sonne J; Larsen S
    Br J Clin Pharmacol; 2002 Aug; 54(2):120-4. PubMed ID: 12207630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grapefruit juice and drug interactions. Exploring mechanisms of this interaction and potential toxicity for certain drugs.
    Bressler R
    Geriatrics; 2006 Nov; 61(11):12-8. PubMed ID: 17112309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations.
    Barry M; Gibbons S; Back D; Mulcahy F
    Clin Pharmacokinet; 1997 Mar; 32(3):194-209. PubMed ID: 9084959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of food intake on presystemic clearance of drugs.
    Melander A; McLean A
    Clin Pharmacokinet; 1983; 8(4):286-96. PubMed ID: 6352137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
    Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
    Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Grapefruit juice and drugs: a hazardous combination?].
    Lohezic-Le Devehat F; Marigny K; Doucet M; Javaudin L
    Therapie; 2002; 57(5):432-45. PubMed ID: 12611197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary effects on drug metabolism and transport.
    Harris RZ; Jang GR; Tsunoda S
    Clin Pharmacokinet; 2003; 42(13):1071-88. PubMed ID: 14531721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.